Judge Quashes Teva Bid To Introduce Generic Evista

A federal judge has permanently blocked Teva Pharmaceuticals USA Inc. from launching a copy of Eli Lilly & Co.'s blockbuster osteoporosis drug Evista, rejecting Teva's argument that four Lilly patents are...

Already a subscriber? Click here to view full article